文献速递骨肌介入CT

CT引导下富血小板血浆与类固醇/麻醉剂注射治疗骶髂关节疼痛的比较:一项随机、单盲、对照试验

Comparison of CT-Guided Platelet-Rich Plasma vs Steroid/Anesthetic Injection for Treatment of Sacroiliac Joint Pain: A Randomized, Single-Blinded, Controlled Trial.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-09-24

该单盲随机对照试验纳入44例经麻醉阻滞确认的慢性骶髂关节疼痛成人患者,随机接受CT引导下富血小板血浆(PRP)或类固醇/麻醉剂注射(SAI),3个月时40例(每组20例)完成分析。两组疼痛均显著减轻(PRP组NRS平均变化-3.0±3.2 vs SAI组-1.8±2.4,P=.24),SAI早期缓解更明显,PRP改善更持久,包括 responder 率(NRS降低≥50%)60% vs 35%(P=.11)及残疾和躯体生活质量改善趋势。作者认为PRP可能是慢性骶髂关节疼痛的安全替代选择,但需更大样本更长随访验证。

要点

  • CT引导下PRP与SAI均可减轻慢性骶髂关节疼痛,3个月时NRS平均变化分别为-3.0±3.2和-1.8±2.4(P=.24)。
  • SAI早期疼痛缓解更明显,PRP在3个月时显示出更持久的改善趋势。
  • NRS降低≥50%的应答率PRP组60% vs SAI组35%(P=.11),差异未达统计学显著。

核心结论

  • PRP和SAI均能改善骶髂关节相关下背痛,PRP起效较慢但可能更持久;PRP似乎是管理慢性骶髂关节疼痛的安全替代皮质类固醇的选择;需要更大样本、更长随访的试验来验证这些发现并指导临床指南。

研究设计与样本

  • 单盲随机对照试验,纳入44例经麻醉阻滞后疼痛缓解≥50%确认的慢性骶髂关节疼痛成人患者,随机接受CT引导下PRP或SAI注射,随访3个月,最终40例(每组20例)纳入分析。

诊断标准与关键数值

  • 慢性骶髂关节疼痛入选标准为麻醉阻滞后疼痛缓解≥50%;主要结局为NRS疼痛评分变化;应答者定义为NRS降低≥50%,PRP组60% vs SAI组35%(P=.11)。

临床应用与阅片要点

  • 作者认为PRP似乎是管理慢性骶髂关节疼痛的安全替代皮质类固醇的选择;作者指出需要更大样本、更长随访的试验来验证这些发现并指导临床指南。

局限性

  • 原文指出需要更大样本、更长随访的试验来验证这些发现并指导临床指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Low back pain (LBP) is a leading cause of disability and health care costs in the United States, with the sacroiliac joint (SIJ) implicated in up to 30% of cases. Treatments such as steroid/anesthetic injection (SAI) and opioids offer short-term relief but are associated with systemic side effects and potential for dependency. Platelet-rich plasma (PRP), a biologically active autologous treatment, has demonstrated regenerative and anti-inflammatory properties that may offer a safer and more durable alternative, with some promise seen in the spine on prior trials. This study aimed to compare clinical effectiveness of CT-guided PRP versus SAI for SIJ-mediated LBP using robust inclusion criteria.

MATERIALS AND METHODS: This single-blinded, randomized controlled trial enrolled 44 adult patients with chronic SIJ pain confirmed by ≥50% pain relief after anesthetic block. Participants were then randomized to receive either PRP or SAI by CT guidance, with outcomes assessed over 3 months. Primary outcome was change in numeric rating scale (NRS) pain scores. Secondary outcomes included modified Oswestry Disability Questionnaire, Short Form-12 quality-of-life metrics, functional mobility, and opioid use.

RESULTS: Forty participants (20 per arm) remained for analysis at 3 months with both groups showing significant pain reduction (PRP versus SAI[mean change ± SD]: -3.0 ± 3.2 versus -1.8 ± 2.4; P = .24). SAI produced greater early relief, whereas PRP demonstrated more sustained improvement, including a nonsignificant trend toward higher responder rates (≥50% NRS reduction; 60% versus 35%; P = .11) and greater gains in disability and physical quality of life at 3 months outcome assessment.

CONCLUSIONS: PRP and SAI both improved SIJ-related LBP, with PRP demonstrating a slower onset but potentially more durable benefit. PRP appears to be a viable, safe alternative to corticosteroids in managing chronic SIJ pain. Larger trials with longer follow-up are warranted to validate these findings and inform clinical guidelines.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Peckham ME, McCormick ZL, Safazadeh G, et al. Comparison of CT-Guided Platelet-Rich Plasma versus Steroid/Anesthetic Injection for Treatment of Sacroiliac Joint Pain: A Randomized, Single-Blinded, Controlled Trial. AJNR Am J Neuroradiol. 2026. PMID: 41876223. doi:10.3174/ajnr.A9307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。